CVE-2025-15577

CVE-2025-15577 is a high-severity vulnerability in Valmet Dna with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-22.

Key facts

Description

An unauthenticated attacker can exploit this vulnerability by manipulating URL to achieve arbitrary file read access.This issue affects Valmet DNA Web Tools: C2022 and older.

Frequently asked questions

What is CVE-2025-15577?
An unauthenticated attacker can exploit this vulnerability by manipulating URL to achieve arbitrary file read access.This issue affects Valmet DNA Web Tools: C2022 and older.
How severe is CVE-2025-15577?
CVE-2025-15577 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2025-15577 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (40th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-15577?
CVE-2025-15577 affects Valmet Dna. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-15577?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2025-15577 have an EU (EUVD) identifier?
Yes. CVE-2025-15577 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-206978.
When was CVE-2025-15577 published?
CVE-2025-15577 was published on 2026-02-12 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Valmet Dna

All CVEs affecting Valmet Dna →

Other CWE-22 (Path Traversal) vulnerabilities

Browse all CWE-22 (Path Traversal) vulnerabilities →